Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Aviron (NasdaqNM:AVIR)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Options | Financials | Reports
Recent Events
Aug 31Price hit new 52-week low ($22.01)
Location
297 North Bernardo Avenue
Mountain View, CA 94043
Phone: (650) 919-6500
Fax: (650) 919-6216
Email: info@aviron.com
Employees (last reported count): 462
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Websites
 ·Home Page
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 15%
·Institutional: 77% (91% of float)
(273 institutions)
·Net Inst. Buying: 1.46M shares (+5.74%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Aviron is a biopharmaceutical company focused on the prevention of disease through innovative vaccine technology. The Company currently is focusing its product development and commercialization efforts on its lead product candidate, FLUMIST, an investigational live virus vaccine delivered as a nasal mist for the prevention of influenza. The Company's goal is to become a leader in the discovery, development, manufacture and marketing of vaccines that are safe, effective and suitable for widespread use. The Company's vaccine development programs are based on techniques for producing attenuated (weakened) live virus vaccines and on its proprietary genetic engineering technologies.
More from Market Guide: Expanded Business Description

Financial Summary
Aviron is a biopharmaceutical company focused on the prevention of disease through innovative vaccine technology, particularly its lead product, FluMist. For the six months ended 6/30/01, revenues rose 21% to $7.9 million. Net loss before acct. change rose 23% to $58.1 million. Revenues reflect the development and commercialization of FluMist. Net loss reflects higher R&D expenses due to increases in development activities.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Compensation
PayExer

C. Boyd Clarke, 52
Chairman, Pres, CEO
$934K$277K
Fred Kurland, 51
Sr. VP and CFO
355K--  
Edward Arcuri, Ph.D., 50
Sr. VP, Operations
361K--  
Harry Greenberg, M.D, 56
Sr. VP, R&D and CSO
158K--  
Carol Olson, 43
Sr. VP, Commercial Devel.
374K436K
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year.
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:AVIRAs of 31-Aug-2001
Price and Volume
52-Week Low
on 31-Aug-2001
$22.01 
Recent Price$22.39 
52-Week High
on 1-Nov-2000
$70.609
Beta1.23 
Daily Volume (3-month avg)1.11M
Daily Volume (10-day avg)749.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y]
52-Week Change-49.1%
52-Week Change
relative to S&P500
-31.7%
Share-Related Items
Market Capitalization$697.0M
Shares Outstanding31.1M
Float26.5M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$9.83 
Earnings (ttm)-$3.34 
Earnings (mrq)-$1.00 
Sales (ttm)$1.30 
Cash (mrq)$13.64 
Valuation Ratios
Price/Book (mrq)2.28 
Price/EarningsN/A 
Price/Sales (ttm)17.28 
Income Statements
Sales (ttm)$33.6M
EBITDA (ttm)-$74.7M
Income available to common (ttm)-$88.4M
Profitability
Profit MarginN/A 
Operating MarginN/A 
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-24.69%
Return on Equity (ttm)-54.77%
Financial Strength
Current Ratio (mrq)10.72 
Debt/Equity (mrq)0.85 
Total Cash (mrq)$417.9M
Short Interest
As of 8-Aug-2001
Shares Short3.54M
Percent of Float13.4%
Shares Short
(Prior Month)
2.28M
Short Ratio1.73 
Daily Volume2.05M
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.